Michael Henderson, M.D.

Michael Henderson, M.D. is the Chief Executive Officer of Navire and the Chief Business Officer of BridgeBio. Dr. Henderson also serves as the Chief Executive Officer for a few of BridgeBio’s affiliates, including QED Therapeutics and Origin Biosciences, and he co-founded one of the BridgeBio’s affiliates, PellePharm. Prior to holding these positions, he spent two years serving as BridgeBio’s Senior Vice President of Asset Acquisition, Strategy and Operations. Before joining BridgeBio, Dr. Henderson worked at McKinsey & Company. Dr. Henderson received his B.A. with high honors in global health with a citation in Spanish from Harvard University and his M.D. with a scholarly concentration in health services and policy from Stanford University, where he was a member of both the Ignite and Leadership in Health Disparities Programs.